☰

Zunyan Dai, Ph.D. - Publications

Affiliations: 
2002 Ohio State University, Columbus, Columbus, OH 
Area:
Pathology, Oncology, Genetics
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Johnson AD, Zhang Y, Papp AC, Pinsonneault JK, Lim JE, Saffen D, Dai Z, Wang D, Sadée W. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenetics and Genomics. 18: 781-91. PMID 18698231 DOI: 10.1097/Fpc.0B013E3283050107  0.326
2008 Dai Z, Papp AC, Wang D, Hampel H, Sadee W. Genotyping panel for assessing response to cancer chemotherapy. Bmc Medical Genomics. 1: 24. PMID 18547414 DOI: 10.1186/1755-8794-1-24  0.336
2007 Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, Su J, Rush LJ, Smith LT, Yu L, Liu C, Dai Z, Chen SS, Wang SH, Costello J, et al. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. Bmc Genomics. 8: 446. PMID 18053125 DOI: 10.1186/1471-2164-8-446  0.561
2007 Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W. MicroRNA expression profiles for the NCI-60 cancer cell panel. Molecular Cancer Therapeutics. 6: 1483-91. PMID 17483436 DOI: 10.1158/1535-7163.Mct-07-0009  0.377
2007 Dai Z, Huang Y, Sadee W, Blower P. Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-. Journal of Medicinal Chemistry. 50: 1896-906. PMID 17367118 DOI: 10.1021/Jm060960H  0.32
2007 Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, Zheng X, Sadee W, Sun D. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemotherapy and Pharmacology. 59: 495-505. PMID 16906425 DOI: 10.1007/S00280-006-0291-9  0.319
2006 Dai Z, Liu S, Marcucci G, Sadee W. 5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). Biochemical and Biophysical Research Communications. 351: 455-61. PMID 17064661 DOI: 10.1016/J.Bbrc.2006.10.055  0.462
2006 Wang Y, Dai Z, Sadee W, Hancock WS. A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. Molecular Pharmaceutics. 3: 566-78. PMID 17009856 DOI: 10.1021/Mp060002B  0.327
2006 Dai Z, Barbacioru C, Huang Y, Sadée W. Prediction of anticancer drug potency from expression of genes involved in growth factor signaling. Pharmaceutical Research. 23: 336-49. PMID 16425089 DOI: 10.1007/S11095-005-9260-Y  0.372
2005 Huang Y, Dai Z, Barbacioru C, Sadée W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Research. 65: 7446-54. PMID 16103098 DOI: 10.1158/0008-5472.Can-04-4267  0.341
2005 Xiao JJ, Huang Y, Dai Z, Sadée W, Chen J, Liu S, Marcucci G, Byrd J, Covey JM, Wright J, Grever M, Chan KK. Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines. The Journal of Pharmacology and Experimental Therapeutics. 314: 467-75. PMID 15833893 DOI: 10.1124/Jpet.105.083956  0.343
2005 Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, Raval A, Liu TH, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L, Marcucci G, et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics. 37: 265-74. PMID 15723065 DOI: 10.1038/Ng1521  0.671
2005 Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, Sadée W. Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1. The Pharmacogenomics Journal. 5: 112-25. PMID 15668728 DOI: 10.1038/Sj.Tpj.6500297  0.347
2005 Xiao JJ, Foraker AB, Swaan PW, Liu S, Huang Y, Dai Z, Chen J, Sadée W, Byrd J, Marcucci G, Chan KK. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1. The Journal of Pharmacology and Experimental Therapeutics. 313: 268-76. PMID 15634944 DOI: 10.1124/Jpet.104.072033  0.338
2004 Yu L, Liu C, Bennett K, Wu YZ, Dai Z, Vandeusen J, Opavsky R, Raval A, Trikha P, Rodriguez B, Becknell B, Mao C, Lee S, Davuluri RV, Leone G, et al. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84: 647-60. PMID 15475242 DOI: 10.1016/J.Ygeno.2004.06.010  0.732
2004 Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Research. 64: 4294-301. PMID 15205344 DOI: 10.1158/0008-5472.Can-03-3884  0.305
2004 Dai Z, Popkie AP, Zhu WG, Timmers CD, Raval A, Tannehill-Gregg S, Morrison CD, Auer H, Kratzke RA, Niehans G, Amatschek S, Sommergruber W, Leone GW, Rosol T, Otterson GA, et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 23: 3521-9. PMID 15116090 DOI: 10.1038/Sj.Onc.1207441  0.609
2004 Zhu WG, Hileman T, Ke Y, Wang P, Lu S, Duan W, Dai Z, Tong T, Villalona-Calero MA, Plass C, Otterson GA. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. The Journal of Biological Chemistry. 279: 15161-6. PMID 14722112 DOI: 10.1074/Jbc.M311703200  0.521
2004 Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu Y, Raval A, Liu T, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L, Marcucci G, et al. Global Assessment of Promoter Methylation in a Murine Model of Cancer Identifies ID4 as a Putative Novel Tumor Suppressor Gene in Human Leukemia. Blood. 104: 3488-3488. DOI: 10.1182/Blood.V104.11.3488.3488  0.626
2003 Li J, Zhang Z, Dai Z, Popkie AP, Plass C, Morrison C, Wang Y, You M. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia (New York, N.Y.). 5: 362-6. PMID 14511407 DOI: 10.1016/S1476-5586(03)80029-5  0.553
2003 Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Molecular and Cellular Biology. 23: 4056-65. PMID 12773551 DOI: 10.1128/Mcb.23.12.4056-4065.2003  0.549
2003 Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A, Wu YZ, Rush LJ, Ross P, Molina JR, Otterson GA, Plass C. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Human Molecular Genetics. 12: 791-801. PMID 12651874 DOI: 10.1093/Hmg/Ddg083  0.573
2003 Li J, Zhang Z, Dai Z, Plass C, Morrison C, Wang Y, Wiest JS, Anderson MW, You M. LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene. 22: 1243-6. PMID 12606951 DOI: 10.1038/Sj.Onc.1206192  0.53
2003 Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, Plass C. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Journal of Medical Genetics. 40: 25-33. PMID 12525538 DOI: 10.1136/Jmg.40.1.25  0.581
2002 Dai Z, Weichenhan D, Wu YZ, Hall JL, Rush LJ, Smith LT, Raval A, Yu L, Kroll D, Muehlisch J, Frühwald MC, de Jong P, Catanese J, Davuluri RV, Smiraglia DJ, et al. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Research. 12: 1591-8. PMID 12368252 DOI: 10.1101/Gr.197402  0.661
2001 Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene. 20: 7787-96. PMID 11753657 DOI: 10.1038/Sj.Onc.1204970  0.643
2001 Dai Z, Lakshmanan RR, Zhu WG, Smiraglia DJ, Rush LJ, Frühwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (New York, N.Y.). 3: 314-23. PMID 11571631 DOI: 10.1038/Sj.Neo.7900162  0.662
2001 Frühwald MC, O'Dorisio MS, Smith L, Dai Z, Wright FA, Paulus W, Jürgens H, Plass C. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan]. Klinische PäDiatrie. 213: 197-203. PMID 11528554 DOI: 10.1055/S-2001-16851  0.595
2001 Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. Oncogene. 20: 5033-42. PMID 11526488 DOI: 10.1038/Sj.Onc.1204613  0.66
2001 Smiraglia DJ, Rush LJ, Frühwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies Human Molecular Genetics. 10: 1413-1419. PMID 11440994 DOI: 10.1093/Hmg/10.13.1413  0.59
2001 Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Frühwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood. 97: 3226-33. PMID 11342453 DOI: 10.1182/Blood.V97.10.3226  0.63
2001 Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes, Chromosomes & Cancer. 30: 38-47. PMID 11107174 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1052>3.0.Co;2-S  0.626
2001 Plass C, Frühwald MC, Rush LJ, Dai Z, Smith LT, Smiraglia DJ. Contribution of DNA methylation to oncogenesis: Results of a genome scanning approach in multiple human tumors Nature Genetics. 27: 80-80. DOI: 10.1038/87252  0.606
1999 Smiraglia DJ, Frühwald MC, Costello JF, McCormick SP, Dai Z, Peltomäki P, O'Dorisio MS, Cavenee WK, Plass C. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics. 58: 254-62. PMID 10373323 DOI: 10.1006/Geno.1999.5840  0.579
Show low-probability matches.